* Antisense Oligonucleotides (updated 2024-12-02) ~ youtor.org

Antisense Oligonucleotides (updated 2024-12-02)

2022 FIRST LOOK Marco Mineo PhD [upl. by Berri635]

2022 FIRST LOOK Marco Mineo PhD

Duration: 7:39
392 views | 2 May 2022

Oligonucléotides antisens et ARNi et leurs applications dans le traitement des maladies métaboliques [upl. by Ark501]

Oligonucléotides antisens et ARNi et leurs applications dans le traitement des maladies métaboliques

Duration: 2:41:01
88 views | 2 months ago

The Brain Conference 24 Advanced Therapies [upl. by Nivak]

The Brain Conference 24 Advanced Therapies

Duration: 1:18:56
200 views | 4 months ago

Antisense oligonucleotide therapy [upl. by Eissolf421]

Antisense oligonucleotide therapy

Duration: 23:35
5.2K views | 28 Feb 2016

How Does It Work Oligonucleotide Therapies [upl. by Loring336]

How Does It Work Oligonucleotide Therapies

Duration: 1:24
2.6K views | 27 Sep 2022

What are Oligonucleotide Therapeutics Therapeutic Oligonucleotides Development [upl. by Zetta]

What are Oligonucleotide Therapeutics Therapeutic Oligonucleotides Development

Duration: 2:14
427 views | 5 months ago

AP Research Oral Defense on Antisense Oligonucleotides to correct a splicing defect by Irene Ortega [upl. by Drisko]

AP Research Oral Defense on Antisense Oligonucleotides to correct a splicing defect by Irene Ortega

Duration: 29:41
19 views | 2 weeks ago

How to synthesize complex custom long oligonucleotides [upl. by Catie781]

How to synthesize complex custom long oligonucleotides

Duration: 2:09
130 views | 10 Oct 2022

Oligonucleotide Synthesis for Therapeutics [upl. by Mendie]

Oligonucleotide Synthesis for Therapeutics

Duration: 2:49
2.4K views | 8 months ago

NanoSIMS Improving the targeting of ASO therapeutic subcellular imaging Webinar [upl. by Rabaj]

NanoSIMS Improving the targeting of ASO therapeutic subcellular imaging Webinar

Duration: 32:09
206 views | 9 months ago

How to order custom Antisense Oligos ASOs [upl. by Silverman324]

How to order custom Antisense Oligos ASOs

Duration: 1:01
50 views | 11 months ago

Antisense oligonucleotides as gene theraputic agents Dr Kariman EHamamsy [upl. by Rekyr461]

Antisense oligonucleotides as gene theraputic agents Dr Kariman EHamamsy

Duration: 20:55
78 views | 7 months ago

Which end of my custom oligo should I add a modification Dharmacon™ Oligo Synthesis Tips Ep 3 [upl. by Kalbli]

Which end of my custom oligo should I add a modification Dharmacon™ Oligo Synthesis Tips Ep 3

Duration: 3:07
19 views | 8 months ago

The Future of Alzheimer’s Treatment Kiersten Smith amp Dr Kissel’s SURE Research [upl. by Soalokcin]

The Future of Alzheimer’s Treatment Kiersten Smith amp Dr Kissel’s SURE Research

Duration: 0:59
61 views | 2 months ago

Oligo resuspension and storage tips Dharmacon™ Oligo Synthesis Tips Episode 6 [upl. by Annavaj]

Oligo resuspension and storage tips Dharmacon™ Oligo Synthesis Tips Episode 6

Duration: 2:27
47 views | 8 months ago

Building a Nanorare Network and Managing Institutional Challenges NRPC24 [upl. by Hurwit760]

Building a Nanorare Network and Managing Institutional Challenges NRPC24

Duration: 33:56
3 views | 3 weeks ago

What synthesis scale should I use Dharmacon™ Oligo Synthesis Tips Episode 1 [upl. by Ahsatniuq]

What synthesis scale should I use Dharmacon™ Oligo Synthesis Tips Episode 1

Duration: 2:43
46 views | 8 months ago

Antisense Drug Oligonucleotide Drugs [upl. by Gairc]

Antisense Drug Oligonucleotide Drugs

Duration: 2:50
994 views | 28 Jan 2020

Volanesorsen A novel treatment for high triglyceride levels [upl. by Nillor]

Volanesorsen A novel treatment for high triglyceride levels

Duration: 5:45
238 views | 3 weeks ago

Closing Remarks The 2nd iXCells Rare Disease Awareness Workshop [upl. by Kleeman829]

Closing Remarks The 2nd iXCells Rare Disease Awareness Workshop

Duration: 3:09
3 views | 9 months ago

Science Sundays Adrian Krainer Shooting the messenger Antisense therapies for rare diseases [upl. by Abih825]

Science Sundays Adrian Krainer Shooting the messenger Antisense therapies for rare diseases

Duration: 1:05:43
32 views | 4 weeks ago

Key role of glutamate tRNA fragments in brain aging and Alzheimers disease [upl. by Rosati]

Key role of glutamate tRNA fragments in brain aging and Alzheimers disease

Duration: 9:27
191 views | 6 months ago

Antisense Oligonucleotides Part 2 [upl. by Bruni705]

Antisense Oligonucleotides Part 2

Duration: 11:58
7.4K views | 17 Dec 2014

Dr Arthur Beaudet Research Update [upl. by Monahon814]

Dr Arthur Beaudet Research Update

Duration: 1:03:11
1.9K views | 30 May 2014

TIDES 2016 Interview Shuling Guo Ionis Pharmaceuticals [upl. by Quar]

TIDES 2016 Interview Shuling Guo Ionis Pharmaceuticals

Duration: 7:20
729 views | 24 Jun 2016

RNA Collaborative University of Michigan Center for RNA Biomedicine January 17 2024 [upl. by Hiett]

RNA Collaborative University of Michigan Center for RNA Biomedicine January 17 2024

Duration: 1:02:02
319 views | 10 months ago

Considerations for oligonucleotide purification Dharmacon™ Oligo Synthesis Tips Episode 4 [upl. by Florine741]

Considerations for oligonucleotide purification Dharmacon™ Oligo Synthesis Tips Episode 4

Duration: 2:56
92 views | 8 months ago

Lafora Disease Rebooting the PatientIndustry Partnership Jeff Milton La Jolla Labs [upl. by Matheny]

Lafora Disease Rebooting the PatientIndustry Partnership Jeff Milton La Jolla Labs

Duration: 29:13
25 views | 9 months ago

How to design antisense oligonucleotides for high ontarget potency and minimal offtarget effect [upl. by Yauq]

How to design antisense oligonucleotides for high ontarget potency and minimal offtarget effect

Duration: 49:46
3.9K views | 12 Jul 2023

Safety of therapeutic oligonucleotides [upl. by Elram]

Safety of therapeutic oligonucleotides

Duration: 1:28:09
4.5K views | 14 May 2020

Our site allows you to download your favorite videos in MP3 (audio) or MP4 (video) format in the most efficient way. You can find your favorite videos using "search" to download them.

New on site

Content Report
youtor.org / Youtor Videos converter © 2024